SHELBY COULTER: Open Payments
NPI 1588141931 · KANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 24 payments from 11 companies in 2025. Trend: 2023 $809 · 2024 $785 · 2025 $438
Food & beverage: $438
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $95 |
| Novartis Pharmaceuticals Corporation | 4 | $67 |
| Boston Scientific Corporation | 2 | $63 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| Novo Nordisk Inc | 2 | $37 |
| Alnylam Pharmaceuticals Inc. | 2 | $34 |
| E.R. Squibb & Sons, L.L.C. | 2 | $30 |
| ABIOMED | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: REPATHA, LEQVIO, WATCHMAN FLX, EVKEEZA, Wegovy, ONPATTRO, CAMZYOS, VERQUVO.
Industry payments across KS — which companies pay providers there.
